5 companies mixing medicine and marijuana

Blackboard with the chemical formula of CBD

The chemical formula of CBD

From eye drops for glaucoma to chewing gum for irritable bowel syndrome, derivatives of cannabis are making their way into FDA trials, fueling a biotech/pharma market that could be worth $20 billion by 2020.

Chief among the molecules of interest is cannabidiol or CBD. Like THC, CBD is believed to have a variety of therapeutic benefits. It does not, however, deliver a hallucinogenic high, making it more suitable for children and adults hoping to live a normal life while taking substantial doses.

Below are five biopharma companies pursuing such therapies, each with its own take on drug delivery and treatment for a diverse range of diseases and disorders.

Zynerba Pharmaceuticals
Devon, Pennsylvania-based Zynerba has both a synthetic gel and a patch that can deliver CBD transdermally. In a field

... read more at: https://medcitynews.com/2017/02/five-companies-medicine-marijuana/